Aton Ra Partners Adaptive Biotechnologies Corp Transaction History

Aton Ra Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.4 - $14.73 $304,576 - $701,000	-47,590 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $189,537 - $541,268	18,729 Added 64.89%	47,590 $661,000
Q4 2021 Feb 14, 2022	BUY	$25.17 - $36.85 $33,954 - $49,710	1,349 Added 4.9%	28,861 $810,000
Q3 2021 Nov 15, 2021	BUY	$30.02 - $39.87 $37,915 - $50,355	1,263 Added 4.81%	27,512 $935,000
Q2 2021 Aug 12, 2021	BUY	$32.22 - $44.59 $845,742 - $1.17 Million	26,249 New	26,249 $1.07 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $812M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

Stay updated on Aton Ra Partners with notifications on news.